Lipocine
LPCN
LPCN
47 hedge funds and large institutions have $24.9M invested in Lipocine in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.69M | |
| 2 | +$2.57M | |
| 3 | +$1.93M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.74M |
| 5 |
SC
Stempoint Capital
New York
|
+$1.4M |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$697K | |
| 3 | -$498K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$40.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$18.4K |
